Bristol Myers Squibb to Take Part in Bernstein’s 37th Annual Strategic Decisions Conference

On May 26, 2021 Bristol Myers Squibb (NYSE: BMY) reported that the company will participate in a fireside chat at Bernstein’s 37th Annual Strategic Decisions Virtual Conference, which will be webcast on Wednesday, June 2, 2021 (Press release, Bristol-Myers Squibb, MAY 26, 2021, View Source [SID1234580595]). Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, will answer questions about the company at 10 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source An archived edition of the session will be available later that day.